A recent British Medical Journal article titled “The Illusion of evidence based medicine” brings to light some of the obvious flaws in our current pre-constitutional administrative state and the glaring financial and political conflicts of interests in medical research.

“The pharmaceutical industry’s responsibility to its shareholders means that priority must be given to their hierarchical power structures, product loyalty, and public relations propaganda over scientific integrity,” that journal states.

Ivermectin. It seems the misinformation cabal of regulatory capture has struck again. Anesthesiologist Madhava Setty provides perspective in his recent article in The Defender, which states “The New York Times on Wednesday sent an email to subscribers titled: ‘Breaking News: Ivermectin failed as a Covid treatment . . .’ The Times was referring to a study in the New England Journal of Medicine, covered March 18 by The Wall Street Journal. In both cases, the newspapers failed to provide an accurate critical analysis of the study.”

Given the article, it is becoming even more clear where the real story is. Neither the Wall Street Journal or The New York Times are willing to pursue details around how corporate interests are corrupting scientific opinion. Instead, these iconic journals chose to report on a scientific study on or prior to the day of publication using misleading headlines backed up by flimsy investigations conducted by journalists with no capacity to dissect the analysis or data.

My concern that the ability to discern, research and dissect information is quickly being replaced by cognitive dissonance and cult-like devotion to sacred authority. This is not alleviated in the least when those with agendas do not look further than what seems to confirm their own bias. No matter which side you’re on, a deeper look is always wise.